Skip to main content

Table 4 Indication frequency by appropriateness of drug and guideline compliance

From: The effectiveness of a simple antimicrobial stewardship intervention in general practice in Australia: a pilot study

(A)
Indication
(B)
Cohort
(C)
Number of prescriptions
(% of total prescriptions)
(D)
Appropriate drug ([D/C]%)a
(E)
Guideline compliance ([E/C]%)a
(F)
Appropriate duration
([F/C]%)a
Respiratory Pre 113 (28.6) 79 (69.9) 44 (38.9) 66 (58.4)
post 95 (25.5) 80 (87.0) 59 (67.8) 87 (94.6)
p value 0.617 0.009 0.004 < 0.001
Ear, nose, throat Pre 77 (19.5) 61 (81.3) 32 (43.8) 33 (44.0)
post 76 (20.4) 71 (94.7) 33 (49.3) 67 (88.2)
p value 0.889 0.016 0.657 < 0.001
Skin and soft tissue Pre 78 (19.7) 60 (76.9) 42 (56.8) 66 (84.6)
post 69 (18.5) 63 (91.3) 35 (54.7) 63 (91.3)
p value 0.854 0.028 0.853 0.244
Urinary tract infection Pre 53 (13.4) 47 (88.7) 16 (31.4) 17 (32.1)
post 54 (14.5) 54 (100.0) 21 (44.7) 39 (72.2)
p value 0.870 0.011 0.411 0.005
Medical prophylaxis Pre 39 (9.9) 18 (46.2) 9 (25.0) 4 (12.9)
post 25 (6.7) 20 (95.2) 16 (84.2) 16 (88.9)
p value 0.657 0.001 0.003 0.002
Genital and sexually transmitted infections Pre 20 (5.1) 16 (80.0) 8 (50.0) 11 (55.0)
post 28 (7.5) 28 (100.0) 8 (72.7) 24 (85.7)
p value 0.739 0.014 0.351 0.048
Gastrointestinal Pre 9 (2.3) 8 (88.9) 8 (88.9) 7 (77.8)
post 20 (5.4) 17 (89.5) 10 (58.8) 16 (84.2)
p value 0.708 0.964 0.157 0.712
  1. a Some missing data ranging from 1 to 17 prescriptions. Percentages calculated based on assessable prescriptions
  2. Other indications: 7 prescriptions (2016), 6 prescriptions (2018)
  3. p value for comparison of proportions between cohorts